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The biological fitness of bone progenitor cells in Reamer Irrigator Aspirator-waste  1 
 2 
Abstract 3 
Background 4 
The biological waste collected during the Reamer-Irrigator-Aspirator (RIA) procedure has 5 
been described as an abundant source of bone progenitor cells with a comparable 6 
osteogenic gene profile to donor-matched iliac crest-bone marrow (IC-BM). However, it is 7 
not clear if these RIA-waste (RIA-W) cells are biologically fit. We aimed to evaluate the stress 8 
levels and functions of RIA-W progenitor cells.  9 
Methods  10 
The Reactive Oxygen Species (ROS) levels were tested in freshly-collected bone progenitor 11 
cells (defined as CD45low CD271high cells) using flow-cytometry. Induced ROS levels in these 12 
cells were measured under hypoxia and/or oxidative stress as well as under experimental 13 
simulation of RIA procedure. Furthermore, the alkaline phosphatase (ALP) expression 14 
levels, proliferation and senescence of culture-expanded RIA-W and IC-BM Mesenchymal 15 
Stromal Cells (MSCs) were compared.  16 
Results  17 
RIA-W and donor-matched IC-BM CD45lowCD271high cells were 97% and 98% viable, but the 18 
ROS levels for RIA-W cells were significantly higher than IC-BM cells (p=0.0020). Also, 19 
hypoxia-, oxidative stress- or both-induced ROS were higher for RIA-W cells (p=0.0312, 20 
p=0.0078, and p=0.0312 respectively). The dilution with saline, suction pressure, and 21 
irrigation-effect reduced cell viability with a positive correlation of the ROS levels 22 
(p=0.0035). The RIA-W and IC-BM colony-forming cells (average 96,100 and 11,000, 23 
respectively) showed comparable ALP levels. Furthermore, culture-expanded RIA-W and 24 
IC-BM MSCs showed comparable ROS, ALP levels, death susceptibility and proliferation.  25 
Conclusions  26 
Although freshly-collected RIA-W bone progenitor cells seemed to be transiently stressed, 27 
these cells were as viable, but higher in numbers than IC-BM cells. The proliferation and 28 
osteogenesis of both cells were comparable. 29 
Clinical Relevance  30 
The RIA-W bag should not be wasted as containing bone progenitor cells with promising 31 
potential for regenerative application.  32 
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Introduction 40 
Bone progenitor cells extracted from bone marrow (BM) are increasingly used for 41 
orthopaedic regenerative procedures. However, considering the donor-related variability (1-42 
4) and rarity of these progenitor cells (5), using even BM concentrates cannot guarantee 43 
enough cells for effective bone repair. In contrast, cortical and trabecular bone cavities 44 
contain significant high numbers of progenitor cell numbers (6, 7) and this difference is 45 
related to the presence of bone lining, stromal and perivascular progenitor cells (6). 46 
Hernigou et. al. reported that around 50,000 progenitor cells (colony-forming) were 47 
required for non-union healing (8). Thus, huge BM aspirate volumes would be needed to 48 
extract adequate progenitor cell numbers helping bone regeneration (1, 2). Consequently, 49 
alternative and abundant sources of bone progenitor cells are highly desirable.  50 
Recently, the Reamer-Irrigator-Aspirator (RIA) device has been introduced in the 51 
clinical setting mostly for bone harvesting procedures (9). During the RIA procedure, the 52 
femoral medullary canal reaming is combined with irrigation with Sodium Chloride 0.9% 53 
(saline) and suction pressure to separate the bone graft from the debris and the fatty tissue 54 
(10, 11). Alongside, a considerable volume of a biological waste bag is usually collected (10). 55 
Interestingly, RIA waste (RIA-W) has been reported to contain an average of 398 56 
colonies/ml comparable with 403 colonies/ml of iliac crest-bone marrow (IC-BM) aspirate 57 
(12, 13). Also, RIA-W bag contains on average 2252 CD45lowCD271high cells/ml, compared 58 
to 1313 cells/ml of IC-BM (12). These CD45low CD271high cells are positively correlated with 59 
colony-forming cell counts, unlike CD45low CD271low cells (1, 14, 15). Additionally, CD45low 60 
CD271high cells uniformly express the classic MSC markers and alkaline phosphatase (ALP) 61 
(1, 2).  62 
Comparing gene expression profile of uncultured RIA-W and IC-BM CD45low 63 
CD271high cells showed that Wnt pathway transcripts; FRZB (frizzled-related protein) and 64 
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SFRP1 and 4 (secreted frizzled-related proteins 1 and 4) as well as several osteogenic-65 
related transcripts; SPP1 (Osteoprotegerin), BMP2, BMP7 (Bone morphogenic proteins), 66 
OMD (Osteomodulin), SPARC (Osteonectin), COL1A2 (Collagen 1A2), and TNFRSF11B 67 
(Osteoprotegrin) were all comparable. However, few hypoxia-related transcripts were 68 
lower in RIA-W cells (12). Another study showed that culture-expanded osteogenic RIA-W 69 
MSCs express ALP and calcium, similar to IC-BM MSCs (16). However, stress status, 70 
viability and proliferation of uncultured RIA-W cells remain unclear. This study aimed to 71 
assess the basal and induced cell stress levels of freshly collected RIA-W CD45lowCD271high 72 
cells compared to donor-matched IC-BM. Additionally, colony-forming cell counts, 73 
osteogenesis and proliferation of the culture-expanded MSCs from both sources were 74 
tested.  75 
 76 
 77 
Patients and Methods 78 
Clinical samples 79 
Patients undergoing RIA femoral procedures (autologous bone graft harvesting) for the 80 
treatment of long bone fracture non-union were invited to participate in this study.  81 
Polytrauma patients with chest injuries undergoing RIA procedures for acute stabilisation of 82 
femoral shaft fractures were excluded. All included patients (total 35 patients, table 1) 83 
provided informed written consent according to the ethical approval with NREC number: 84 
06/Q1206/127, National Research Ethics Committee Yorkshire & HumberにLeeds East. For 85 
comparative analysis, donor-matched RIA-W bag (average 650ml, 400-900 ml) and 15 ml of 86 
BM was harvested by the same (the senior) surgeon from the anterior iliac crest, collected 87 
into 20 ml syringe with multiple suctions and changing angles. Samples were transferred 88 
immediately into EDTA-containing tubes (4, 11). 89 
 90 
 91 
Processing of RIA-W bags and BM aspirates   92 
The donor-matched RIA-W and IC-BM samples were filtered to exclude clumps/debris then 93 
were treated with red blood cell lysis buffer (NH4Cl, KCL and EDTA). Total live cells were 94 
counted using Trypan blue. Separated cells were processed without culture or expanded in 95 
StemMACS MSC Expansion medium with Foetal-calf serum and L-glutamine (130-104-182, 96 
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Miltenyi-Biotec) and analysed for colony-forming cells or at passage 3. The antibodies 97 
against CD73, CD90, CD105 (positive MSC markers) and CD45, CD14, CD19 and HLA-DR 98 
(negative MSC markers) (Miltenyi-Biotec and Beckton-Dickson) were used to prove that 99 
culture-expanded cells were MSCs (17). The BD LSRII 4-laser flow-cytometer and the DIVA 100 
software (Beckton-Dickson) were used for data acquisition and analysis, respectively. 101 
 102 
Measuring cell stress levels and death susceptibility 103 
The reactive oxygen species (ROS) levels were measured using Green CellROX® kit (C10492, 104 
ThermoFisher Scientific) that includes a dye exhibiting bright fluorescence upon oxidation 105 
by ROS. Freshly-collected CD45low CD271high cells (1, 2) or culture-expanded MSCs  (17, 18) 106 
were analysed similarly for ROS levels. The SYTOX dye (ThermoFisher Scientific) was used to 107 
exclude the dead cells.  108 
For induced stress, cells were kept in 1% oxygen (H35 HEPA Hypoxystation, Don 109 
Whitley Scientific) for one hour for freshly-collected cells or five days for culture-expanded 110 
MSCs. Anti-hypoxia induced factor (HIF, Beckton-Dickson) antibody was used to confirm 111 
hypoxic cell response. Alternatively, cells were exposed to an oxidative stress-inducing 112 
chemical, tetra-butyl hydroperoxide (TBHP, 800µM, ThermoFisher), or hypoxia and TBHP 113 
together. Cells treated with a higher dose of TBHP (15mM) were analysed using SYTOX for 114 
dead cell susceptibility. 115 
 116 
Experimental mimicking of the RIA procedure 117 
To simulate the RIA procedure, IC-BM samples were processed subsequently with different 118 
treatments. Each IC-BM sample was mixed 1:10 with phosphate buffered saline (Sigma-119 
Aldrich) only or this IC-BM/saline mixture was exposed to impulse mixing using Vortex (V-1 120 
plus, Biosan) for continuous 3 minutes mimicking the reaming/ irrigation effect. The suction 121 
pressure effect was tested via multiple aspirations of 10 ml of the IC-BM/saline mixture into 122 
50 ml syringe. All samples were analysed for CellROX and stained with a live cell marker, 123 
Calcein violet (ThermoFisher). 124 
 125 
The osteogenic assays 126 
Freshly-collected RIA-W and IC-BM cells were equally seeded (1x106 cells/dish) for one 127 
week in the expansion medium to allow cell plastic-adhesion then in the osteogenic medium 128 
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(130-091-678, Miltenyi-Biotec) for two more weeks. Numbers of colonies formed by 129 
colony-forming cells (progenitor cells) were counted manually. The ALP expression in 130 
colonies was visualised using fast-blue dye kit (Sigma-Aldrich). Colony area and integrated 131 
density were analysed using ImageJ software (NIH). 132 
For the quantitative measurement of ALP in culture-expanded MSCs maintained in 133 
the osteogenic medium for two weeks, the surface ALP levels were tested using flow-134 
cytometry and specific antibody (Miltenyi-Biotec). 135 
 136 
The proliferation of culture-expanded MSCs 137 
The proliferation was assessed using the XTT assay kit (11465015001, Merck). The XTT 138 
buffer containing Tetrazolium salts was added to MSCs cultures in  1% or 21% oxygen for 139 
six days. The dye cleaves to coloured formazan by the succinate-tetrazolium reductase in 140 
metabolically intact cells, indicating cell proliferation. 141 
To assess the MSC senescence status in cultures, a kit (75707, ThermoFisher) was 142 
used to measure lysosomal Beta-G;ﾉ;IデﾗゲｷS;ゲW ふé-gal) that catalyses the hydrolysis of 143 
デWヴﾏｷﾐ;ﾉ é-linked galactose residues. In senescent cells, high é-gal activity is detectable at 144 
pH-6, and a reagent containing O-nitrophenyl-beta-D-galactopyranoside will be lysed, 145 
giving coloured O-nitrophenyl that was measured optically. 146 
 147 
Statistics 148 
The statistical analysis and figure preparation were performed using GraphPad Prism 7. The 149 
comparative tests for paired RIA-W and IC-BM groups were performed as indicated for each 150 
figure.  151 
 152 
 153 
Funding source 154 
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 158 
Results 159 
Freshly-collected RIA-W progenitor cells appeared alive but more stressed than IC-BM cells  160 
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The stress status of RIA-W cells was evaluated with flow-cytometry; using forward and side 161 
cell scatters (FSC and SSC) to identify cells and excluding debris based on size and 162 
granularity respectively (Figure 1, A) then SYTOX dye to exclude dead cells before gating on 163 
CD45lowCD271high cells (Figure 1, A). The total median numbers of viable cells were 164 
comparable (20x107 and 31x107, respectively, Figure 1, B). Additionally, an average of 98% 165 
and 97% viable CD45lowCD271high cells were detected in IC-BM and RIA-W samples, 166 
respectively. The cell stress was measured via quantifying the mean fluorescence intensity 167 
(MFI) of CellROX dye indicating the expression of ROS levels in freshly-collected RIA-W 168 
CD45lowCD271high cells relative to donor-matched IC-BM cells (Figure 1, C). Interestingly, RIA-169 
W CD45lowCD271high cells had consistently greater levels of CellROX dye than donor-matched 170 
IC-BM cells (2.3-fold, p=0.0020; Figure 1, D). Similarly, RIA-W CD45high cells (hematopoietic 171 
lineage cells) had higher MFI levels of CellROX dye than donor-matched RIA-W CD45high cells 172 
(1.9-fold, p=0.0012), (Figure 1, E). Overall, RIA-W cells appeared to be more stressed than 173 
donor-matched IC-BM cells.  174 
 175 
 176 
Higher induced ROS and death susceptibility of freshly-collected RIA-W progenitor cells than 177 
IC-BM cells 178 
A further investigation of the stress status for freshly collected RIA-W cells, particularly in 179 
response to hypoxia, was conducted. Cell incubation under 1% oxygen for 1 hour was 180 
adequate to induce HIF levels in the RIA-W CD45lowCD271high cells (Figure 2, A). The 181 
oxidative stress reagent, TBHP was used a positive control, and its titration showed a dose-182 
dependent increase of cellular ROS and death levels (Figure 2, B & C). When cells exposed to 183 
hypoxia, TBHP, or both, higher ROS levels were detected (an example is shown for RIA-W 184 
CD45lowCD271high cells, Figure 2, D). The comparison of donor-matched samples showed 185 
higher hypoxia-induced ROS levels in RIA-W CD45lowCD271high cells (mean of 1.6-fold, 186 
p=0.0312, Figure 2, E). The TBHP-induced ROS levels were consistently greater in RIA-W 187 
CD45lowCD271high cells than donor-matched IC-BM (mean of 3.5-fold, p=0.0078, Figure 2, E). 188 
Similarly, applying hypoxia and TBHP showed more ROS levels in RIA-W than IC-BM cells 189 
(mean of 1.5-fold, p=0.0312, Figure 2, E). Furthermore, exposure to 15mM TBHP for one 190 
hour induced a cell death (Figure 2, F). Importantly, The TBHP-induced dead cell 191 
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percentages of RIA-W CD45lowCD271high were higher than IC-BM cells (p=0.0234, Figure 2, G) 192 
together confirming the apparent greater stress for RIA-W cells. 193 
 194 
 195 
The RIA processing affected freshly-collected cell viability, but proliferation and osteogenic 196 
capacity appeared intact 197 
An experimental simulation of the RIA procedure was performed using freshly-collected IC-198 
BM cells. The CellROX MFI for CD45lowCD271high cells diluted with saline, then subsequently 199 
treated by suction pressure or vortex were similar to the untreated control (Figure 3, A). 200 
However, the percentages of live cells (i.e. Calcein violet+) among CD45lowCD271high cells 201 
were significantly decreased after subsequent treatments (p=0.0158, p=0.0401 and 202 
p=0.0181 respectively, Figure 3, B). Furthermore, a significant positive correlation between 203 
dead cell percentages and ROS levels was detected for TBHP-treated RIA-W 204 
CD45lowCD271high cells (p=0.0035, Figure 3, C) indicating that the RIA procedure could 205 
contribute to freshly-collected RIA-W cell stress.  206 
RIA-W were seeded in the osteogenic media to assess if the high-stress level could 207 
have a further impact on the osteogenesis of colony-forming cells. The average total 208 
colony-forming cell counts were 11,500 and 96,100 for IC-BM (15-ml) and RIA-W (650-ml) 209 
respectively, and all colonies were positively stained for ALP (Figure 3, D). Of note, the ALP-210 
stained colony areas were not significantly different for RIA-W and IC-BM samples 211 
(p=0.5293), (Figure 3, E). Furthermore, the integrated densities of ALP-stained colonies were 212 
comparable for RIA-W and IC-BM samples (p=0.5069), (Figure 3, F). Collectively, RIA-W and 213 
IC-BM-derived colonies had similar proliferation and ALP expression.  214 
 215 
 216 
RIA-W MSCs had comparable surface phenotype, ROS levels and death susceptibility to IC-217 
BM MSCs  218 
Further investigations for longer-term fitness of RIA-W culture-expanded cells were 219 
performed. The RIA-W and IC-BM culture-expanded cell identity as MSCs was similarly 220 
confirmed as negatively expressed hematopoietic markers; CD45, CD19, CD14, and HLA-DR, 221 
and being nearly 100% positively expressed CD73, CD90, and CD105 (Figures 4, A and B). 222 
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There were no significant differences in the positive marker expression levels between 223 
donor-matched RIA-W and IC-BM MSCs (Figure 4, C) indicating similar surface phenotype. 224 
The culture-expanded RIA-W MSCs showed similar basal CellROX levels to IC-BM 225 
MSCs (MFI: 1104 and 1048 respectively), with no significant difference (p=0.6455), (Figure 4, 226 
D). Additionally, the hypoxia, TBHP, or both-induced CellROX levels were comparable for 227 
cultured RIA-W MSCs and IC-BM MSCs (p=0.3408, p=0.8278, and p=0.8297 respectively), 228 
(Figure 4, E). Furthermore, there was no significant difference of the TBHP-induced dead cell 229 
percentages between culture-expanded RIA-W MSCs and IC-BM MSCs (p=0.1875, medians 230 
36 and 41% respectively), (Figure 4, F). Altogether, the higher stress and death susceptibility 231 
of RIA-W cells seemed to normalise after culture-expansion.  232 
 233 
 234 
The osteogenesis and proliferation of RIA-W MSCs were similar to IC-BM MSCs 235 
As similar ROS levels were detected for culture-expanded RIA-W and IC-BM MSCs, we next 236 
compared their surface ALP levels using flow-cytometry (Figure 5, A). The ALP levels were 237 
significantly induced in osteogenic cultures compared to the expansion cultures for RIA-W 238 
and IC-BM MSCs (p=0.0213, p=0.0029 respectively), (Figure 5, B). However, no difference 239 
was noted for ALP levels between differentiating RIA-W and IC-BM MSCs (p=0.6056), (Figure 240 
5, B). 241 
A gradual increase of the XTT absorbance levels from the lowest to the highest MSC 242 
concentration were comparably noted for 1% and 21% O2 (Figure 5, C).  However, a lower 243 
XTT level trend under 1% O2 was observed for the lowest cell concentration (2-fold less). 244 
These proliferation patterns were equally detected for RIA-W and IC-BM MSCs (Figure 5, C). 245 
Finally, é-gal levels were measured to assess if these RIA-W MSCs were going into 246 
senescence earlier than donor-matched IC-BM MSCsく IﾐデWヴWゲデｷﾐｪﾉ┞が デｴW é-gal levels were 247 
equal for both RIA-W and IC-BM MSCs under 21% or 1% O2 (Figure 5, D) confirming the 248 
similar proliferative potential for RIA-W and IC-BM MSCs. 249 
 250 
 251 
Discussion 252 
For bone regenerative therapies, the need for accessible and abundant sources for bone 253 
progenitor cells is essential. Our data confirmed a high yield of bone progenitor cells in 254 
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RIA-W consistently with previous studies (12, 13). The RIA-W bag (650ml) contained on 255 
average 96,1000 progenitor cells, which is potentially adequate for improving of non-256 
union fracture healing (8). We also uniquely reported the proliferative and osteogenic 257 
fitness of these progenitor cells. Noteworthy, this is the first study measuring the stress 258 
levels in progenitor cells using a flow-cytometry based method, and detecting higher stress 259 
levels for RIA-W freshly-collected progenitor cells (CD45lowCD271high cells) than donor-260 
matched IC-BM at the basal and induced levels.  261 
We hypothesized that the RIA procedure, including irrigation, suction and 262 
dilution/storage in saline could trigger this RIA-W cell stress as donor-matched IC-BM 263 
aspirate cells were exposed only to suction pressure. As anticipated, the experimental RIA 264 
mimicking caused significant MSC death. Although no difference was detected in ROS levels, 265 
the cell stress coupling with pro-death susceptibility has been noted in our study and other 266 
previous reports (19, 20) as excess ROS can disturb cell signalling and apoptosis pathways 267 
(20). Together, the RIA procedure most likely caused the apparent RIA-W cell stress. 268 
Our results indicated that RIA-W-derived colonies or MSCs maintained their ALP 269 
expression. Furthermore, when culture-expanded under 21% or 1% O2 (hypoxia), RIA-W 270 
MSCs retained comparable ROS levels and being able to proliferate without early 271 
senescence thus can adapt to in vitro culture conditions (21). These results demonstrated a 272 
temporary and reversible RIA-W cell stress status and confirmed the key role of the external 273 
environment in biological cell fitness.  274 
We modelled here potentially hostile environments (hypoxia) that MSCs could face 275 
following their delivery/application into the disadvantaged bone healing site (22). Also, 276 
using a control oxidative-stressing agent, TBHP and the flow cytometry-based method 277 
quantifying ROS levels can be beneficial for future investigations of the stress in other bone 278 
healing-related cells, e.g. endothelial cells and immune cells (23, 24). Our data suggested 279 
that hypoxia did not alter the culture-expanded MSC proliferation except for low-density 280 
seeded cells. This note can be explained, as suggested before, by a hypoxia-related 281 
quiescent state for low-cell numbers to protect against apoptosis (25, 26). Also, hypoxia has 282 
been shown to reduce the high passaged MSC senescence ふｷくWく д ヶ ヮ;ゲゲ;ｪWゲぶ (27), but we 283 
aimed was to check if early-passaged RIA-W MSCs undergo senescence limiting the 284 
comparison with these data.  285 
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As a limitation of our study, we used CD73, CD90 and CD105 as MSC markers, 286 
which have not been shown to correlate with in vitro or in vivo proliferation or 287 
differentiation assays. Moreover, culture-expanded MSCs were reported as widely 288 
variable in expressing pluripotent markers and other markers, e.g. CD146 (28). Therefore, 289 
future in vivo assessment of culture-expanded MSCs will be needed.  290 
In summary, besides having adequate progenitor cell quantities, RIA-W cells 291 
showed higher stress signs soon after collection. However, this stress seemed to be 292 
temporary, reversible and related to the RIA procedure. Compared to IC-BM, RIA-W cells 293 
can efficiently survive, proliferate and are fit for bone formation even when minimally-294 
cultured. For therapeutic exploitation, these RIA-W cells could be concentrated/enriched 295 
using low-stress procedures without centrifugation, e.g. dielectrophoretic cell separation 296 
(29). Also, the RIA-W cell storage could be improved by including nutritious media in the 297 
collection bag as recommended for bone grafts (30, 31) and at low temperature (32). 298 
Considering our findings, the wasted RIA-W bag in routine surgical practice could be of great 299 
clinical value as an abundant source of functionally-competent bone progenitor cells.   300 
 301 
 302 
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 435 
Figure legends 436 
Figure 1: The basal ROS levels of freshly-collected in RIA-W and IC-BM cells. 437 
A. The gating strategy on flow-cytometry plots. The cell scatters were used on FSC/SSC plot 438 
to exclude debris then live cells were identified as SYTOX negative cells, then 439 
CD45lowCD271high cells were used as a surrogate of the freshly-collected bone progenitor 440 
cells.  441 
B. The total live cells after processing of RIA-W and IC-BM were counted using trypan blue. 442 
C. The histograms for mean fluorescence intensity (MFI) of CellROX in CD45lowCD271high cells 443 
of donor-matched IC-BM aspirates and RIA-W samples as an indicator of cellular ROS levels.  444 
D. The comparison of MFI levels of CellROX for CD45lowCD271high cells between donor-445 
matched RIA-W and IC-BM samples (n=10). *: p value<0.05, Wilcoxon matched-pairs signed 446 
rank test.  447 
E. The comparison of MFI levels of CellROX for CD45high cells between donor-matched RIA-W 448 
and IC-BM samples (n=10). *: p value<0.05, Wilcoxon matched-pairs signed rank test.  449 
 450 
Figure 2: The induced ROS levels and death susceptibility of freshly-collected 451 
CD45lowCD271high cells in RIA-W bag compared to IC-BM samples. 452 
A. The MFI levels of HIF in RIA-W CD45lowCD271high cells under 1-hour 21% O2 or hypoxia (1% 453 
O2). The bars represent the mean of 3 samples with the standard error of the mean. 454 
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B. The bars represent the mean percentage (with the standard error) of dead cells (SYTOX+) 455 
among RIA-W CD45lowCD271high cells following treatment with different doses of TBHP, n=5. 456 
C. The MFI levels of CellROX RIA-W CD45lowCD271high cells following treatment with different 457 
doses of TBHP. The bars represent the mean of 5 samples with the standard error of the 458 
mean. 459 
D. The overly histograms showing the MFI of CellROX expressed in freshly-collected 460 
CD45lowCD271high cells without or with exposure to hypoxia (1% O2) and/or 800µM TBHP.   461 
E. The bars present the mean with the standard error of the mean of CellROX MFI for donor-462 
matched samples (n=6) from IC-BM aspirate and RIA-W bag. *: p value<0.05, Wilcoxon 463 
matched-pairs signed rank test. 464 
F. The flow cytometry plots for gating strategy of measuring the percentages of dead cells 465 
among freshly-collected CD45lowCD271high RIA-W cells exposed to 15mM TBHP for 1 hour.  466 
G. The comparison of the percentages of dead cells among CD45lowCD271high cells between 467 
freshly-collected and donor-matched RIA-W and IC-BM after treatment with TBHP. *: p 468 
value<0.05, Paired t-test. 469 
 470 
Figure 3: The effect of the RIA procedure and the proliferation and osteogenesis of RIA-W 471 
and IC-BM colonies. 472 
A. The MFI levels of CellROX in IC-BM CD45lowCD271high cells either not processed (control) 473 
or diluted with 1:10 saline, then additionally processed with suction or by vortex (n=5). *: p 474 
value<0.05, Paired t-test. 475 
B. The percentage of live cells (Calcein violet+ cells) among CD45lowCD271high cells following 476 
dilution with saline, then with additional processing with suction or by vortex compared to 477 
the control sample (n=5). 478 
C. The correlation between the percentage of dead cells (SYTOX+) of CD45lowCD271high cells 479 
and the MFI of CellROX in live cells when freshly-collected RIA-W cells (n=5) were treated 480 
with different concentrations of TBHP (400µM, 800µM, 8mM, 15mM). *: p value<0.05, 481 
r=0.5608, Spearman r test (n=20). 482 
D. The RIA-W and IC-BM colonies showing ALP staining after culture in the osteogenic 483 
medium.  484 
E. The bars represent the mean of the area of colonies (with the error of means) when 485 
compared between RIA-W and IC-BM (n=6) using Image J software. 486 
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F. The bars represent the mean of the integrated density of colonies (with the error of 487 
means) when compared between RIA-W and IC-BM (n=6) using Image J software. 488 
 489 
Figure 4: The phenotype, ROS levels and death susceptibility of culture-expanded RIA-W 490 
and IC-BM MSCs. 491 
A. The flow cytometry histograms showing the surface phenotype of passage 3 culture-492 
expanded MSCs from RIA-W and IC-BM samples. Both types of cells were tested using 493 
antibodies for hemopoietic cell markers (CD45, CD19, CD14, and HLA-DR) and the positive 494 
MSC markers (CD73, CD90, and CD105). Grey histograms represent the isotype controls, and 495 
the black and dark grey histograms represent the RIA-W and IC-BM test samples.  496 
B. The bars represent the mean percentage of passage 3 culture-expanded RIA-W and IC-497 
BM cells expressing surface markers (n=3). 498 
C. The bars represent the mean of MFI (with the standard error of means) for the positive 499 
markers when compared between passage 3 culture-expanded RIA-W and IC-BM cells (n=3).  500 
D. The comparison of the basal the CellROX MFI between passage 3 cultured RIA-W and IC-501 
BM MSCs (n=4).  502 
E. The comparison of the induced the CellROX MFI between passage 3 cultured RIA-W and 503 
IC-BM MSCs with exposure to hypoxia and/or TBHP (n=4). The bars represent the mean of 504 
the CellROX MFI with the standard error of means. 505 
F. The dot plot shows the mean percentages of dead cells (SYTOX+) of culture-expanded 506 
RIA-W and IC-BM MSCs after treatment with TBHP (n=6). 507 
 508 
Figure 5: The osteogenesis, proliferation, and senescence of cultured RIA-W MSCs and IC-509 
BM MSCs. 510 
A. The flow cytometry plots showed the gating strategy for the cells based on FCS and SSC 511 
scatters, then MSCs were identified as CD73+CD90+ CD105+CD45-cells. The grey histogram 512 
represents ALP expression in MSCs cultured in the osteogenic medium compared to ones 513 
cultured in the expansion medium (black histogram).  514 
B. A comparison of surface ALP levels between donor-matched RIA-W and IC-BM MSCs 515 
cultured in either the expansion or the osteogenic milieu. The figure shows the mean levels 516 
with the standard error of means (n=3) *: p value<0.05, Paired t-test. 517 
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C. The proliferation of culture-expanded donor-matched RIA-W and IC-BM MSCs was 518 
compared under 21% and 1% O2 conditions. The bars present the mean of the XTT 519 
absorbance levels with the standard error of the mean (n=6). Three cell concentrations were 520 
seeded (250, 500 and 1000 cells, black, white and grey bars respectively) per well of 96-well 521 
plate.  522 
D. The senescence of donor-matched culture-expanded RIA-W MSCs and IC-BM MSCs was 523 
compared under 21% and 1% O2 conditions. The figure presents the mean of é-gal levels 524 
(with the standard error of the mean) for donor-matched samples (n=8).  525 
